The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 7, 2004, Pages 3313-3318

  Malkin, Chris J ^a   Pugh, Peter J ^a   Jones, Richard D ^b   Kapoor, Dheeraj ^b,c   Channer, Kevin S ^a   Jones, T Hugh ^b,c  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c BARNSLEY DISTRICT GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPID; PLACEBO; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG EFFECT; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADULT; AGED; CHOLESTEROL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; CYTOKINES; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-10; LIPIDS; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; TESTOSTERONE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3242667701     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031069     Document Type: Article

References (45)

1. Cutolo M, Wilder RL 2000 Different roles for androgens and escrogens in the susceptibility to autoimmune rheumatic diseases. Rheum Dis Clin North Am 26:825-839
2. Dalal M, Kim S, Voskuhl RR 1997 Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J Immunol 159:3-6
3. Kimura M, Tanaka S, Yamada Y, Kiuchi Y, Yamakawa T, Sekihara H 1998 Dehydroepiandrosterone decreases serum tumor necrosis factor-α and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats. Endocrinology 139:3249-3253
4. Ben-Nathan D, Padgett DA, Loria RM 1999 Androstenediol and dehydroepiandrosterone protect mice against lethal bacterial infections and lipopolysaccharide toxicity. J Med Microbiol 48:425-431
5. Cutolo M, Balleari E, Giusti M, Intra E, Accardo S 1991 Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum 34:1-5
6. Bizzarro A, Valentini G, Di Martino G, DaPonte A, De Bellis A, Iacono G 1987 Influence of testosterone therapy on clinical and immunological features of autoimmune diseases associated with Klinefelter's syndrome. J Clin Endocrinol Metab 64:32-36
7. Olsen NJ, Kovacs WJ 1995 Case report: testosterone treatment of systemic lupus erythematosus in a patient with Klinefelter's syndrome. Am J Med Sci 310:158-160
8. D'Agostino P, Milano S, Barbera C, Di Bella G, La Rosa M, Ferlazzo V, Farruggio R, Miceli DM, Miele M, Castagnetta L, Cillari E 1999 Sex hormones modulate inflammatory mediators produced by macrophages. Ann NY Acad Sci 876:426-429
9. Li ZG, Danis VA, Brooks PM 1993 Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol 11:157-162
10. Gornstein RA, Lapp CA, Bustos-Valdes SM, Zamorano P 1999 Androgens modulate interleukin-6 production by gingival fibroblasts in vitro. J Periodontol 70:604-609
11. Bellido T, Jilka RL, Boyce BF, Girasole G, Broxmeyer H, Dalrymple SA, Murray R, Manolagas SC 1995 Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J Clin Invest 95:2886-2895
12. Hofbauer LC, Ten RM, Khosla S 1999 The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line. J Bone Miner Res 14:1330-1337
13. Hatakeyama H, Nishizawa M, Nakagawa A, Nakano S, Kigoshi T, Uchida K 2002 Testosterone inhibits tumor necrosis factor-α-induced vascular cell adhesion molecule-1 expression in human aortic endothelial cells. FEBS Lett 530:129-132
14. + T lymphocytes to increase IL-10 production. J Immunol 167:2060-2067
15. Bebo Jr BF, Schuster JC, Vandenbark AA, Offner H 1999 Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J Immunol 162:35-40
16. Spinedi E, Suescun MO, Hadid R, Daneva T, Gaillard RC 1992 Effects of gonadectomy and sex hormone therapy on the endotoxin-stimulated hypothalamo-pituitary-adrenal axis: evidence for a neuroendocrine-immunological sexual dimorphism. Endocrinology 131:2430-2436
17. Wichmann MW, Ayala A, Chaudry IH 1997 Male sex steroids are responsible for depressing macrophage immune function after trauma-hemorrhage. Am J Physiol 273:C1335-C1340
18. Khosla S, Atkinson EJ, Dunstan CR, O'Fallon WM 2002 Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. J Clin Endocrinol Metab 87:1550-1554
19. Yesilova Z, Ozata M, Kocar IH, Turan M, Pekel A, Sengul A, Ozdemir IC 2000 The effects of gonadotropin treatment on the immunological features of male patients with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 85:66-70
20. Ng MK, Liu PY, Williams AJ, Nakhla S, Ly LP, Handelsman DJ, Celermajer DS 2002 Prospective study of effect of androgens on serum inflammatory markers in men. Arterioscler Thromb Vasc Biol 22:1136-1141
21. Lambert CP, Sullivan DH, Evans WJ 2003 Effects of testosterone replacement and/or resistance training on interleukin-6, tumor necrosis factor α, and leptin in elderly men ingesting megestrol acetate: a randomized controlled trial. J Gerontol A Biol Sci Med Sci 58:165-170
22. Tremblay RR, Dube JY 1974 Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. Contraception 10:599-605
23. Sliwa K, Skudicky D, Candy G, Wisenbaugh T, Sareli P 1998 Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy. Lancet 351:1091-1093
24. Anker SD, Coats AJ 2002 How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. Int J Cardiol 86:123-130
25. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E 2000 Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction. Circulation 101:2149-2153
26. Pinderski LJ, Fischbein MP, Subbanagounder G, Fishbein MC, Kubo N, Cheroutre H, Curtiss LK, Berliner JA, Boisvert WA 2002 Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes. Circ Res 90:1064-1071
27. Waehre T, Halvorsen B, Damas JK, Yndestad A, Brosstad F, Gullestad L, Kjekshus J, Froland SS, Aukrust P 2002 Inflammatory imbalance between IL-10 and TNFα in unstable angina potential plaque stabilizing effects of IL-10. Eur J Clin Invest 32:803-810
28. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML, Zeiher AM 2003 Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107:2109-2114
29. Oppenheim DS, Greenspan SL, Zervas NT, Schoenfeld DA, Klibanski A 1989 Elevated serum lipids in hypogonadal men with and without hyperprolactinemia. Ann Intern Med 111:288-292
30. Hromadova M, Hacik T, Malatinsky E, Sklovsky A, Cervenakov J, Labady F 1991 Lipid metabolism in young males with hypotestosteronaemia and oligospermia prior to, during, and after treatment. Int Urol Nephrol 23:69-75
31. Whitsel EA, Boyko EJ, Matsumoto AM, Anawalt BD, Siscovick DS 2001 Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis. Am J Med 111:261-269
32. Tenover JS 1992 Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 75:1092-1098
33. Sorva R, Kuusi T, Taskinen MR, Perheentupa J, Nikkila EA 1988 Testosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hypogonadal males. Atherosclerosis 69:191-197
34. Marin P, Holmang S, Jonsson L, Sjostrom L, Kvist H, Holm G, Lindstedt G, Bjorntorp P 1992 The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 16:991-997
35. Simon D, Charles MA, Lahlou N, Nahoul K, Oppert JM, Gouault-Heilmann M, Lemort N, Thibult N, Joubert E, Balkau B, Eschwege E 2001 Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial. Diabetes Care 24:2149-2151
36. Musial J, Undas A, Gajewski P, Jankowski M, Sydor W, Szczeklik A 2001 Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia. Int J Cardiol 77:247-253
37. Solheim S, Seljeflot I, Arnesen H, Eritsland J, Eikvar L 2001 Reduced levels of TNFα in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks. Atherosclerosis 157:411-415
38. Fak AS, Erenus M, Tezcan H, Caymaz O, Atagunduz P, Oktay S, Oktay A 2000 Effects of simvastatin only or in combination with continuous combined hormone replacement therapy on serum lipid levels in hypercholesterolaemic post-menopausal women. Eur Heart J 21:190-197
39. Sbarouni E, Kyriakides ZS, Kremastinos D 1998 The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease. J Am Coll Cardiol 32:1244-1250
40. Pugh PJ, Malkin CJ, Morris PD, Asif S, Jones RD, Jones TH, Channer KS 2003 Prevalence of hypogonadism in men with coronary disease. J Am Coll Cardiol 41:344A
41. Vermeulen A, Kaufman JM 1995 Ageing of the hypothalamo-pituitary- testicular axis in men. Horm Res 43:25-28
42. English KM, Steeds RP, Jones TH, Diver MJ, Channer KS 2000 Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation 102:1906-1911
43. Rosano GM, Leonardo F, Pagnotta P, Pelliccia F, Panina G, Cerquetani E, della Monica PL, Bonfigli B, Volpe M, Chierchia SL 1999 Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation 99:1666-1670
44. Malkin CJ, Pugh PJ, Morris PD, Kerry KE, Jones RD, Jones TH, Channer KS 2004 Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and mood. Heart, in press
45. Pugh PJ, Jones RD, West JN, Jones TH, Channer KS 2004 Testosterone treatment for men with chronic heart failure. Heart 90:446-447